Clearside Biomedical
CLSD
CLSD
60 hedge funds and large institutions have $37.4M invested in Clearside Biomedical in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
35% less capital invested
Capital invested by funds: $57.8M → $37.4M (-$20.3M)
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Holders
60
Holding in Top 10
1
Calls
$470K
Puts
$579K
Top Buyers
| 1 | +$1.58M | |
| 2 | +$998K | |
| 3 | +$943K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$266K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$181K |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$1.65M | |
| 3 | -$1.39M | |
| 4 |
Morgan Stanley
New York
|
-$1.06M |
| 5 |
Two Sigma Advisers
New York
|
-$508K |